MFN2 and amyotrophic lateral sclerosis: At the same time, the abundance of MFN2 was drastically decreased in ALS fibroblasts, particularly in the advanced stages of the disease, indicating a possible involvement of this protein in the pathological mechanisms underlying ALS progression (Figure 6D).